New Report Available: Global Preventive Asthma Drugs Market 2015-2019

According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The symptoms worsen due to the increased secretion of mucus, bronchoconstriction, and thickening of the walls of the airways, resulting in difficulty in expiration. According to the American Academy of Allergy, Asthma, and Immunology, asthma is classified into four types: exercise-induced, allergic, occupational, and childhood. Also, asthma can be classified into two categories: allergic and non-allergic, as per the classification of Asthma and Allergy Foundation of America. Asthma can be managed by preventive medications, which should be administered to the patient regularly to improve his quality of life by controlling the exacerbations.

Full Report Details at
- http://www.fastmr.com/prod/1060725_global_preventive_asthma.aspx?afid=301

Technavio's analysts forecast the global preventive asthma drugs market to grow at a CAGR of 5.20% over the period 2014-2019.

Covered in this report
This report covers the present scenario and the growth prospects of the global preventive asthma drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of the following classes of drugs used to treat asthma:

* Immunosuppressants
* Leukotriene antagonists
* Mast cell stabilizers
* Corticosteroids
* Combination of LABA/ ICS

This report includes a discussion of the market in the following three regions:

* Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil
* EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
* APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India

Technavio's report, Global Preventive Asthma Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global preventive asthma drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

* Americas
* APAC
* EMEA

Key vendors

* AstraZeneca
* F. Hoffmann-La Roche
* GlaxoSmithKline
* Merck
* Novartis

Other prominent vendors

* Abbott
* Amgen
* AptarGroup
* Biotest
* Boehringer Ingelheim
* Chiesi Farmaceutici
* Cytos
* Dainippon Sumitomo
* Medicinova
* Mylan
* Novartis
* Orchid Chemicals and Pharmaceuticals
* Pfizer
* Rottapharm Madaus
* Skyepharma
* Sosei
* Sunovion
* Teva Pharmaceutical
* Theravance

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations
- Allergic Asthma Global Clinical Trials Review, H2, 2014
- Chronic Asthma Global Clinical Trials Review, H2, 2014
- Acute Asthma Global Clinical Trials Review, H2, 2014
- Global Asthma Market 2014-2018